CN Stock MarketDetailed Quotes

600196 Shanghai Fosun Pharmaceutical

Watchlist

23.48
-0.14-0.59%

Market Closed Jan 13 15:00 CST

62.72BMarket Cap29.68P/E (TTM)

Shanghai Fosun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai Fosun Pharmaceutical Q4 2024 Estimates Date

Currency：HKDMar 26, 2025

	Estimate	YoY
Revenue	11.53B	-0.64%
EPS	0.29	+564.77%

Analyst Rating

Strong Buy

Jan 13, 2025

Shanghai Fosun Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 10.266B	--
--	2024/Q4	-- / 10.839B	--
--	2024/Q3	10.449B / 10.338B	--
--	2024/Q2	10.226B / 10.561B	--
--	2024/Q1	10.157B / 10.691B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 10.266B--

--2024/Q4-- / 10.839B--

--2024/Q310.449B / 10.338B--

--2024/Q210.226B / 10.561B--

--2024/Q110.157B / 10.691B--

Unlock Free Earnings Estimates

Open Account

Shanghai Fosun Pharmaceutical Earnings Reports

Fosun Pharmaceuticals 2024 Third Quarter Report

Oct 29, 2024 12:00 ET

Fosun Pharmaceutical 2024 Semi-Annual Report

Aug 27, 2024 12:00 ET

Summary of Fosun Pharmaceutical\'s 2024 Semi-Annual Report

Aug 27, 2024 12:00 ET

Fosun Pharmaceuticals 2024 First Quarter Report

Apr 29, 2024 12:00 ET

Symbol Price % Chg

Suzhou Everbright Photonics

Shenzhen Ampron Technology

301413

77.97 +17.37%

Shenzhen Boshijie Technology

301608

73.50 +15.51%

See the daily top gainer.

Analysis

Analyst Rating

Updated: Jan 13, 2025

Strong Buy

Strong Buy
77.78%
Buy
22.22%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Monoclonal Antibody Concept

Intraday+0.51%